Using a novel magnetic resonance imaging (MRI) based biomarker, the proton-density-fat-fraction (MRI-PDFF),we compared pancreatic fat content in patients with biopsy-proven NAFLD to healthy controls and determined whether it isassociated with insulin resistance and liver fat content. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.